hemostatic efficacy

Related by string. * Hemostatic : immunologic hemostatic . hemostatic gauze . hemostatic bandage . innovative hemostatic . TM hemostatic bandage . hemostatic agent . hemostatic agents / EFFICACY . Efficacy : primary efficacy endpoint . secondary efficacy endpoints . antimicrobial efficacy . preclinical efficacy . Demonstrates Efficacy . primary efficacy endpoints . analgesic efficacy * *

Related by context. Frequent words. (Click for all words.) 67 analgesic efficacy 66 fluvastatin 66 thromboprophylaxis 65 QTc prolongation 65 active comparator 65 PREZISTA r 65 paclitaxel eluting stents 64 clopidogrel Plavix 63 lanthanum carbonate 63 Thrombolysis 63 tigecycline 63 irbesartan 63 ximelagatran 63 mycophenolate mofetil 63 coadministration 63 REVLIMID lenalidomide 62 thromboembolism 62 carotid artery stenting 62 FOLFOX4 62 Engerix B 62 J Am Coll 62 pharmacokinetics PK 62 NOXAFIL 62 transurethral resection 62 Tolerability 62 pharmacokinetic parameters 62 randomized controlled clinical trials 62 voriconazole 62 immunohistochemical 62 ketorolac 62 Secondary endpoints 61 thromboembolic events 61 efficacy tolerability 61 PRADAXA 61 docetaxel chemotherapy 61 Secondary endpoints include 61 Solid Tumors 61 Natalizumab 61 azacitidine 61 alteplase 61 nab paclitaxel 60 Pivotal Phase III 60 intravesical 60 oxybutynin 60 beta blocker therapy 60 Amiodarone 60 goserelin 60 Rivaroxaban 60 tirofiban 60 Vertebroplasty 60 PROMACTA 60 pharmacodynamic effects 60 surrogate endpoint 60 plus prednisone 60 placebo controlled studies 60 coronary intervention 60 Rasilez Tekturna 60 Adalimumab 60 unfractionated heparin 60 ReoPro 60 teriparatide 60 stent implantation 60 Traficet EN 60 Diovan HCT 60 pharmacokinetic PK 60 pharmacokinetic profiles 60 severe renal impairment 60 PRISTIQ 60 antibiotic prophylaxis 60 eplerenone 59 Patients Undergoing 59 nonoperative 59 therapeutic regimens 59 Patient Outcomes 59 Navelbine 59 APTIVUS 59 ischemic cardiomyopathy 59 Fludara 59 carboplatin paclitaxel 59 glatiramer acetate 59 patients evaluable 59 Immunogenicity 59 TAXUS Stent 59 NeuroStar TMS Therapy 59 indinavir 59 tecarfarin 59 nonrandomized 59 receiving VELCADE 59 tissue plasminogen activator tPA 59 Enoxaparin 59 mg kg dose 59 fulvestrant 59 C1 INH 59 INTEGRILIN 59 Keppra R 59 DOXIL 59 SCH # 59 Amrubicin 59 Stenting 59 enzastaurin 59 Percutaneous Coronary Intervention

Back to home page